Intelligence Β· Clinical Pipeline

Janssen-Cilag International N.V Pipeline

All ClinicalTrials.gov programs at Janssen-Cilag International N.V β€” phase, modality, and trial IDs.

Programs
1

Quick answer

Janssen-Cilag International N.V has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Guselkumab 1 mL PFS Placebo, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL

    Janssen-Cilag International N.V.

    Psoriatic Arthritis

    approved small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Janssen-Cilag International N.V have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs